Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

443
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
443
Vaccinations01:51

Vaccinations

45.6K
Overview
45.6K
Cancer Vaccines01:30

Cancer Vaccines

542
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
542
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential biomarker and composite efficacy readout for human clinical trials of schistosomiasis vaccine in Africa.

Scientific reports·2025
Same author

Schistosomiasis in the Philippines: A Comprehensive Review of Epidemiology and Current Control.

Tropical medicine and infectious disease·2025
Same author

Vaccine value profile for schistosomiasis.

Vaccine·2024
Same author

Examining the Acceptability of Helminth Education Packages "Magic Glasses Lower Mekong" and "Magic Glasses Opisthorchiasis" and Their Impact on Knowledge, Attitudes, and Practices Among Schoolchildren in the Lower Mekong Basin: Protocol for a Cluster Randomized Controlled Trial.

JMIR research protocols·2024
Same author

Molecular Characterization and Functional Analysis of a <i>Schistosoma mansoni</i> Serine Protease Inhibitor, Smserpin-p46.

Microorganisms·2024
Same author

Transmission-Blocking Vaccines against Schistosomiasis Japonica.

International journal of molecular sciences·2024

Related Experiment Video

Updated: Oct 2, 2025

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules
05:30

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules

Published on: August 16, 2011

18.3K

Vaccines for Human Schistosomiasis: Recent Progress, New Developments and Future Prospects.

Adebayo J Molehin1, Donald P McManus2, Hong You2

  • 1Department of Microbiology and Immunology, College of Graduate Studies, Midwestern University, Glendale, AZ 85308, USA.

International Journal of Molecular Sciences
|February 26, 2022
PubMed
Summary

Schistosomiasis vaccines are urgently needed as drug resistance to praziquantel is a growing concern. This review highlights progress and advocates for new technologies like mRNA and CRISPR to develop effective anti-schistosome vaccines.

Keywords:
clinical vaccine developmentmRNA vaccineschistosomiasis

More Related Videos

Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni
12:05

Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni

Published on: January 14, 2018

9.4K
Isolation and Characterization of Extracellular Vesicles from Adult Schistosoma japonicum
07:37

Isolation and Characterization of Extracellular Vesicles from Adult Schistosoma japonicum

Published on: May 22, 2018

8.0K

Related Experiment Videos

Last Updated: Oct 2, 2025

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules
05:30

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules

Published on: August 16, 2011

18.3K
Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni
12:05

Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni

Published on: January 14, 2018

9.4K
Isolation and Characterization of Extracellular Vesicles from Adult Schistosoma japonicum
07:37

Isolation and Characterization of Extracellular Vesicles from Adult Schistosoma japonicum

Published on: May 22, 2018

8.0K

Area of Science:

  • Parasitology
  • Tropical Medicine
  • Vaccinology

Background:

  • Schistosomiasis is a major neglected tropical disease caused by parasitic blood flukes.
  • Current treatment relies on praziquantel, raising concerns about drug resistance.
  • Despite promising antigens, no schistosomiasis vaccine is currently available.

Purpose of the Study:

  • To review the progress of schistosomiasis vaccines in clinical development.
  • To advocate for the urgent development of novel anti-schistosome vaccines.
  • To emphasize the need for advanced technologies in vaccine design and deployment.

Main Methods:

  • Review of current clinical development of schistosomiasis vaccines.
  • Analysis of challenges and opportunities in vaccine research.
  • Discussion of emerging technologies for vaccine development.

Main Results:

  • Several schistosome vaccine antigens have been identified, but none have reached deployment.
  • The development of a schistosomiasis vaccine is a global health priority.
  • Existing control strategies face limitations due to potential drug resistance.

Conclusions:

  • There is an urgent need for a sustainable schistosomiasis vaccine pipeline.
  • Cutting-edge technologies, including mRNA and CRISPR, are crucial for future vaccine discovery.
  • Novel vaccine strategies are essential to combat schistosomiasis effectively and sustainably.